A_2B adenosine receptor signaling and regulation

Area of Science:

• Pharmacology
• Molecular Biology
• Cell Biology

Background:

• The A2B adenosine receptor (A2B R) is a G protein-coupled receptor activated by adenosine.
• Protein kinase C (PKC) also activates A2B R, which is expressed in various cell types including cancer cells and smooth muscle cells.
• A2B R signaling is implicated in asthma, cancer, diabetes, and inflammation, with dual pro- and anti-inflammatory roles.

Purpose of the Study:

• To summarize the multifaceted roles of the A2B adenosine receptor (A2B R) in various physiological and pathological processes.
• To highlight the involvement of protein kinase C (PKC) in A2B R activation and signaling.
• To discuss the therapeutic potential and current research directions for A2B R modulation.

Main Methods:

• Literature review of studies on A2B adenosine receptor (A2B R) function and signaling.
• Analysis of A2B R expression in different cell types and disease models.
• Examination of the interaction between A2B R, protein kinase C (PKC), and other signaling pathways.

Main Results:

• A2B R is expressed in numerous cell types and tissues, contributing to diverse functions.
• A2B R exhibits context-dependent pro- and anti-inflammatory effects, influencing cytokine secretion.
• Both A2B R and PKC play roles in cardioprotection, and their signaling can be inhibited by antagonists.
• Inhibitors of PKC and A2B R are under clinical investigation for cancer treatment.
• Natural compounds like sulforaphane can inhibit A2B R signaling through interaction with a specific cysteine residue.

Conclusions:

• The A2B adenosine receptor (A2B R) is a significant target for therapeutic intervention in conditions like cancer, asthma, and cardiovascular disease.
• Understanding the complex signaling of A2B R, including its interaction with PKC, is crucial for developing effective treatments.
• Further research, including the development of selective agonists, is needed to fully elucidate the roles of A2B R and optimize therapeutic strategies.